The end of the heparin pump? Low molecular weight heparins have practical advantages, but clinical advantages are small.
Stein
K
K
Nicholson
T
T
D000925:Anticoagulants / Q000191:economics*; D003327:Coronary Disease / Q000191:economics*; D003362:Cost-Benefit Analysis; D017984:Enoxaparin / Q000191:economics; D006495:Heparin, Low-Molecular-Weight / Q000191:economics*; D006801:Humans
D000925:Anticoagulants; D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight